This chapter delves into the regulatory process of gaining approval for the medical device FEMACED, emphasizing collaboration with the FDA and the challenges encountered. It underscores the importance of conducting prospective studies and data collection for a successful commercial launch to support women and couples in their reproductive health goals.
Watch Carol and Tim LIVE every day on YouTube: http://bit.ly/3vTiACF.
Kathy Lee-Sepsick, CEO at Femasys, discusses an accessible, safe, and cost-effective alternative to IVF.
Hosts: Carol Massar and Tim Stenovec. Producer: Paul Brennan.
See omnystudio.com/listener for privacy information.